What risks does Beam face in its clinical development programs? Beam’s reliance on novel base editing technology introduces inherent risks in its clinical development programs. The long-term ...

Not everyone is convinced. Short-sellers warn that biotech companies like Beam face steep financial challenges. Jim Chanos, known for spotting overvalued stocks, believes ARK often gets caught up ...

A Rotorua company's modified crane became a weapon that changed the life of a teenage contractor, who required major surgery.